Sillajen, Inc.
Records under this name other than the patents Sillajen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 2 of 2 · Back to Sillajen, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,919,047 | Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus Lapsed on the fee record Ended Mar 20, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 20, 2026 | From the USPTO record |
| US 9,856,258 | (5,6-dihydro)pyrimido[4,5-E]indolizines Surrendered on reissue Surrendered on reissue Mar 15, 2022 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Mar 15, 2022 | From the USPTO record |